AIF1 and glioblastoma: Counting of GPNMB+/IBA1+ cells in each tissue specimen resulted in a mean percentage of 11.26% in non-tumor controls (Ctrl) and 66.06% in GBM slices (p = 0.0019; Fig. 6C).